ClinicalTrials.gov - Information on Clinical Trials and Human Research Studies: Browse: University of Virginia, Health Sciences Center Cancer Center


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Include trials that are no longer recruiting patients.

1.	Recruiting	Sargramostim and/or Montanide ISA-51 in Treating Patients With Stage I or Stage II Melanoma Conditions: Recurrent Melanoma; stage I melanoma; stage II melanoma
2.	Recruiting	Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer Conditions: stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; peritoneal cavity cancer
3.	Recruiting	Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colon Cancer Conditions: recurrent colon cancer; stage II colon cancer; stage III colon cancer; stage IV colon cancer
4.	Recruiting	Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery Conditions: intraocular melanoma; Melanoma
5.	Recruiting	Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
6.	Recruiting	Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma Conditions: stage II melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma